Cagent Vascular
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease
$41MSeries D
Role not disclosedActivity from announced rounds
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease